Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,268,400 | 2,818,600 | 2,067,000 | 3,818,500 | 3,657,100 |
| Marketable Securities | 154,800 | 109,100 | 144,800 | 90,100 | 24,200 |
| Receivables | 13,275,400 | 11,336,200 | 8,558,900 | 8,127,200 | 6,929,000 |
| Inventories | 7,589,200 | 5,772,800 | 4,309,700 | 3,886,000 | 3,980,300 |
| Other current assets | 111,400 | 149,500 | 7,300 | 0 | 0 |
| TOTAL | $32,739,700 | $25,727,000 | $18,034,500 | $18,452,400 | $17,462,100 |
| Non-Current Assets | |||||
| PPE Net | 17,102,400 | 12,913,600 | 10,144,000 | 8,985,100 | 8,681,900 |
| Investments And Advances | 3,215,900 | 3,052,200 | 2,901,800 | 3,212,600 | 2,966,800 |
| Intangibles | 6,166,300 | 6,906,600 | 7,206,600 | 7,691,900 | 7,450,000 |
| Other Non-Current Assets | 19,490,600 | 15,406,900 | 11,202,900 | 10,464,000 | 10,072,300 |
| TOTAL | $45,975,200 | $38,279,300 | $31,455,300 | $30,353,600 | $29,171,000 |
| Total Assets | $78,714,900 | $64,006,300 | $49,489,800 | $48,806,000 | $46,633,100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 8,700 |
| Accounts payable and accrued liabilities | 3,228,600 | 2,598,800 | 1,930,600 | 1,670,600 | 1,606,700 |
| Other current liabilities | 18,684,600 | 16,620,700 | 12,689,300 | 10,831,400 | 9,600,500 |
| TOTAL | $28,376,600 | $27,293,200 | $17,138,200 | $15,052,700 | $12,481,600 |
| Non-Current Liabilities | |||||
| Long Term Debt | 28,527,100 | 18,320,800 | 14,737,500 | 15,346,400 | 16,586,600 |
| Other Non-Current Liabilities | 7,539,600 | 7,528,600 | 6,838,700 | 7,518,400 | 9,639,800 |
| TOTAL | $36,066,700 | $25,849,400 | $21,576,200 | $24,598,500 | $28,326,300 |
| Total Liabilities | $64,443,300 | $53,142,600 | $38,714,400 | $39,651,200 | $40,807,900 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 948,170 | 950,165 | 950,296 | 952,347 | 958,426 |
| Common Shares | 592,400 | 593,600 | 594,100 | 596,300 | 598,200 |
| Retained earnings | 13,545,000 | 10,312,300 | 10,042,600 | 8,958,500 | 7,830,200 |
| Other shareholders' equity | -7,255,100 | -7,248,600 | -6,731,700 | -7,180,400 | -9,325,700 |
| TOTAL | $14,271,600 | $10,863,700 | $10,775,400 | $9,154,800 | $5,825,200 |
| Total Liabilities And Equity | $78,714,900 | $64,006,300 | $49,489,800 | $48,806,000 | $46,633,100 |